158 related articles for article (PubMed ID: 27240056)
1. Role of frameshift ubiquitin B protein in Alzheimer's disease.
Chen X; Petranovic D
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):300-13. PubMed ID: 27240056
[TBL] [Abstract][Full Text] [Related]
2. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
Tank EM; True HL
PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
[TBL] [Abstract][Full Text] [Related]
3. Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
Chadwick L; Gentle L; Strachan J; Layfield R
Neuropathol Appl Neurobiol; 2012 Apr; 38(2):118-31. PubMed ID: 22082077
[TBL] [Abstract][Full Text] [Related]
4. Molecular misreading: the occurrence of frameshift proteins in different diseases.
van Leeuwen FW; Kros JM; Kamphorst W; van Schravendijk C; de Vos RA
Biochem Soc Trans; 2006 Nov; 34(Pt 5):738-42. PubMed ID: 17052186
[TBL] [Abstract][Full Text] [Related]
5. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
van Leeuwen FW; Hol EM; Fischer DF
J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
[TBL] [Abstract][Full Text] [Related]
6. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.
Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J
Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease-associated mutant ubiquitin (UBB
Wagh AR; Sulakshane P; Glickman MH
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194936. PubMed ID: 37075976
[TBL] [Abstract][Full Text] [Related]
9. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM; van Leeuwen FW; Fischer DF
Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
[TBL] [Abstract][Full Text] [Related]
10. Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.
De Vrij FM; Sluijs JA; Gregori L; Fischer DF; Hermens WT; Goldgaber D; Verhaagen J; Van Leeuwen FW; Hol EM
FASEB J; 2001 Dec; 15(14):2680-8. PubMed ID: 11726544
[TBL] [Abstract][Full Text] [Related]
11. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration.
Tan Z; Sun X; Hou FS; Oh HW; Hilgenberg LG; Hol EM; van Leeuwen FW; Smith MA; O'Dowd DK; Schreiber SS
Cell Death Differ; 2007 Oct; 14(10):1721-32. PubMed ID: 17571083
[TBL] [Abstract][Full Text] [Related]
12. Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates.
Verhoef LG; Heinen C; Selivanova A; Halff EF; Salomons FA; Dantuma NP
FASEB J; 2009 Jan; 23(1):123-33. PubMed ID: 18796559
[TBL] [Abstract][Full Text] [Related]
13. The Molecular Misreading of APP and UBB Induces a Humoral Immune Response in Alzheimer's Disease Patients with Diagnostic Ability.
Montero-Calle A; San Segundo-Acosta P; Garranzo-Asensio M; Rábano A; Barderas R
Mol Neurobiol; 2020 Feb; 57(2):1009-1020. PubMed ID: 31654319
[TBL] [Abstract][Full Text] [Related]
14. UBB
Chen X; Muñoz-Arellano AJ; Petranovic D
Aging (Albany NY); 2021 Nov; 13(21):23953-23980. PubMed ID: 34751669
[TBL] [Abstract][Full Text] [Related]
15. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
Fischer DF; van Dijk R; van Tijn P; Hobo B; Verhage MC; van der Schors RC; Li KW; van Minnen J; Hol EM; van Leeuwen FW
Neurobiol Aging; 2009 Jun; 30(6):847-63. PubMed ID: 18760506
[TBL] [Abstract][Full Text] [Related]
16. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.
Sulistio YA; Heese K
Mol Neurobiol; 2016 Mar; 53(2):905-931. PubMed ID: 25561438
[TBL] [Abstract][Full Text] [Related]
17. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
18. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
[TBL] [Abstract][Full Text] [Related]
19. +1 Proteins and aging.
van Leeuwen FW; Gerez L; Benne R; Hol EM
Int J Biochem Cell Biol; 2002 Nov; 34(11):1502-5. PubMed ID: 12200043
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.
Fischer DF; De Vos RA; Van Dijk R; De Vrij FM; Proper EA; Sonnemans MA; Verhage MC; Sluijs JA; Hobo B; Zouambia M; Steur EN; Kamphorst W; Hol EM; Van Leeuwen FW
FASEB J; 2003 Nov; 17(14):2014-24. PubMed ID: 14597671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
